Tainwala Chem. (TAINWALCHM)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Zero debt with D/E of 0.00 provides a clean, low-risk balance sheet.
• Promoter holding of 67.51% keeps management aligned with minority shareholders.
• Piotroski F-Score of 7/9 suggests improving fundamentals.
• Sales growth of 43.06% and latest quarterly net profit of ₹3 Cr on ₹10 Cr sales show recovery momentum.
• P/B of 1.22 and Graham Number of ₹204.46 indicate the stock is not far from book-value support.

Concerns

• DCF intrinsic value of ₹63.49 is far below the market price of ₹199.77, leaving no margin of safety.
• ROE of 6.92% and ROCE of 4.24% show poor returns on capital.
• Altman Z-Score of 1.78 falls in the caution/distress zone despite zero debt.
• Free cash flow of only ₹1 Cr is weak relative to reported profits, raising questions about earnings quality.

AI Analysis

At first glance, Tainwala Chem looks like a stock in recovery. Sales grew 43% and profit exploded over 1,100%, but I have learned to be suspicious of numbers that look too good. A 1,116% profit gain usually means the base was very low, not that a durable franchise has appeared. Latest quarter shows ₹10 Cr sales and ₹3 Cr net profit, which is a fine margin, yet free cash flow is only ₹1 Cr. Profits without cash are not profits I can trust. The balance sheet is clean: zero debt is always a plus, and 67.51% promoter holding means owners are still on board. Piotroski score of 7 out of 9 also suggests some fundamental improvement. But let's keep this in perspective. Return on equity is just 6.92%, and return on capital employed is only 4.24%. That is not what I call a wonderful business. Plastic industrial products likely lack pricing power and a durable moat. I cannot ignore Altman Z-Score of 1.78. Even with no debt, the score sits in the caution/distress zone. That forces me to check whether earnings quality is real. Now valuation: The Graham Number is ₹204.46, just above the price, so the stock is trading at a tiny negative margin of safety of -2.31%. But my DCF estimate, using visible cash generation, gives ₹63.49 per share. That is a massive gap. P/E of 18.42 for a business earning 6.92% ROE is not cheap, and EV/EBITDA of 9.72 is not distressed pricing. The PEG of 0.55 is an illusion created by a low-base earnings jump. So what is this? Maybe a turnaround, perhaps a cyclical recovery, but not a predictable compounder. I prefer paying a fair price for a wonderful company, not a questionable price for an average one. I will watch from the sidelines unless consistent cash flow and better returns on capital appear.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer